Author:
Kim Sang Woo,Ha Byung Jin,Kim Eung Kweon,Tchah Hungwon,Kim Tae-im
Reference28 articles.
1. Bevacizumab for neovascular ocular diseases;Lynch;Ann Pharmacother,2007
2. A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents;Hosseini;Med Hypotheses,2007
3. Corneal neovascularization;Chang;Curr Opin Ophthalmol,2001
4. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis);Azar;Trans Am Ophthalmol Soc,2006
5. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing;Gan;Acta Ophthalmol Scand,2004
Cited by
187 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献